Ardais Corporation



Ardais Corporation, a leading clinical genomics company, is dedicated to enhancing and accelerating biomedical research.

  • 11 - 50


Last Funding Type
Series C
Last Funding Money Raised
Biotechnology,Clinical Trials,Genetics,Health Care
Founded date
Apr 1, 1996
Number Of Employee
11 - 50
Operating Status

Ardais Corporation is a clinical genomics company, is dedicated to enhancing and accelerating biomedical research by introducing actual human disease into the pharmaceutical discovery research process. To achieve its goals, Ardais has incorporated multi-disciplinary scientific expertise into its operations, including pathology, molecular biology and genomics, statistical genomics, bioinformatics and medical informatics, as well as process management skills such as logistics, industrial engineering, and robotics. The result of this unique integration is a state-of-the-art, proprietary discovery platform that is dramatically transforming genomic research and leading the way to novel diagnostic and therapeutic solutions.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
Ardais Corporation has raised a total of $47.50M in funding over 2 rounds. Their latest funding was raised on Jan 13, 2003 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 13, 2003 Series C $14M 1 Advent International Detail
Mar 20, 2001 Series B $33.50M 1 Detail


Number of Lead Investors
Number of Investors
Ardais Corporation is funded by 2 investors. Advent International and EGS Healthcare Capital Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Advent International Yes Series C
EGS Healthcare Capital Partners Series B